The stock hit a fresh 52-week high on Tuesday after the announcement. It rose by 4.4% to ₹1,123.4 at the end of the day. It has nearly doubled since February 1 following business momentum.
This is the third big order for Anupam in a month taking the cumulative value of contracts to around ₹2,500 crore. The total order backlog would cross ₹5,000 crore after the company's recent order which would improve revenue visibility for the next 5-7 years.
Anand Desai, managing director of Anupam Rasayan, said, "We have established a new relationship with an American MNC customer by signing a long-term LOI to supply a niche fluorinated molecule on an exclusive basis."
The second-order fluorinated chemistry-based molecules will help the company to achieve the target of earning nearly one-third of revenue from fluorine agents in the next three-four years. It expects revenue of ₹1,000-1,100 crore from the segment which typically fetches higher realisation and enjoys superior margins.
Read More News on
Download The Economic Times News App to get Daily Market Updates & Live Business News.
Top Trending Stocks: SBI Share Price, Axis Bank Share Price, HDFC Bank Share Price, Infosys Share Price, Wipro Share Price, NTPC Share Price